Advertisement

Current Use of Dermatologic Radiotherapy in the United States

Chapter

Abstract

Radiation therapy was a widely used therapeutic modality for cancer and inflammatory disease by dermatologists for many decades. A noticeable decrease in the use of radiation therapy by many practicing dermatologists began in the 1960s. Reasons for the decreased use during this time period included the introduction of more effective topical and systemic drugs for benign entities and increasing public awareness of the biological effects and hazards of ionizing radiation. With regard to the use of radiotherapy for non-melanoma skin cancer by dermatologists, the development of fellowships in Mohs micrographic surgery greatly diminished the need for dermatologic radiotherapy beginning in the mid-1970s. Continued de-emphasis in the teaching, use, and practical application of dermatologic radiotherapy by training institutions and the American Academy of Dermatology could potentially remove this once-useful modality from the armamentarium of dermatologists.

Keywords

Skin Cancer Basal Cell Carcinoma Tinea Capitis Fractionation Schedule Mohs Micrographic Surgery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Goldschmidt H. Ionizing radiation therapy in dermatology. Current use in the United States and Canada. Arch Dermatol. 1975;111(11):1511–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Goldschmidt H. Dermatologic radiotherapy 1981. Arch Dermatol. 1981;117(11):685–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Whaley JT. Non-melanoma skin cancers. The Abramson Cancer Center of the University of Pennsylvania: OncoLink; 2011. http://www.oncolink.org/types/article.cfm?c=18&s=88&ss=866&id=9624&CFID=52640767&CFTOKEN=91975169. Accessed 19 May 2012.
  4. 4.
    Marchetti M, Salmaso R, Polonio S, Perin D, Salviato T, Onnis A. Ki-67 expression in vulvar carcinoma. Preliminary results. Eur J Gynaecol Oncol. 1996;17(5):361–4.PubMedGoogle Scholar
  5. 5.
    Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146(3):283–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Shore RE, Albert RE, Reed M, Harley N, Pasternack BS. Skin cancer incidence among children irradiated for ringworm of the scalp. Radiat Res. 1984;100(1):192–204.PubMedCrossRefGoogle Scholar
  7. 7.
    Epstein E. Thyroid cancer due to X-ray treatment of acne. JAMA. 1969;209(10):1529–30.PubMedCrossRefGoogle Scholar
  8. 8.
    Ehring F, Gattwinkel U. Radiotherapy of upper lip basalioma. Hautarzt. 1974;25(8):368–72.PubMedGoogle Scholar
  9. 9.
    Bart RS, Kopf AW, Petratos MA. X-ray therapy of skin cancer: evaluation of a “standardized” method for treating basal-cell epitheliomas. Proc Natl Cancer Conf. 1970;6:559–69.PubMedGoogle Scholar
  10. 10.
    Goldschmidt H, Breneman JC, Breneman DL. Ionizing radiation therapy in dermatology. J Am Acad Dermatol. 1994;30(2 Pt 1):157–82; quiz 83–6.Google Scholar
  11. 11.
    Halpern JN. Radiation therapy in skin cancer. A historical perspective and current applications. Dermatol Surg. 1997;23(11):1089–93.PubMedCrossRefGoogle Scholar
  12. 12.
    Upton AC. Radiation carcinogenesis. In: Bush H, editor. Methods in cancer research. New York: Academic; 1967.Google Scholar
  13. 13.
    Karapurkar AP, Pandya SK, Desai AP. Radiation induced sarcoma. Surg Neurol. 1980;13(6):419–22.PubMedGoogle Scholar
  14. 14.
    Bodian AB. Equipment and financial aspects in an office setting. In: Panizzon RG, Cooper JS, editors. Radiation treatment and radiation reactions in dermatology. New York: Springer; 2004. p. 25–31.CrossRefGoogle Scholar
  15. 15.
    Kingery FA. Radiation therapy in dermatologic training centers. J Am Acad Dermatol. 1986;14(6):1108–10.PubMedCrossRefGoogle Scholar
  16. 16.
    Schalock PC, Carter J, Zug KA. Use of ionizing radiation in dermatologic training centers. J Am Acad Dermatol. 2006;55(5):912–3.PubMedCrossRefGoogle Scholar
  17. 17.
    Rogers HW, Coldiron BM. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol. 2009;61(1):96–103.PubMedCrossRefGoogle Scholar
  18. 18.
    Cognetta AB, Howard B, Heaton H, Stoddard E, Hong HG, Green WH. Superficial X-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol. 2012;67(6):1235–41.PubMedCrossRefGoogle Scholar
  19. 19.
    Schulte KW, Lippold A, Auras C, Bramkamp G, Breitkopf C, Elsmann HJ, et al. Soft X-ray therapy for cutaneous basal cell and squamous cell carcinomas. J Am Acad Dermatol. 2005;53(6):993–1001.PubMedCrossRefGoogle Scholar
  20. 20.
    Alam M, Berg D, Bhatia A, Cohen JL, Hale EK, Herman AR, et al. Association between number of stages in Mohs micrographic surgery and surgeon-, patient-, and tumor-specific features: a cross-sectional study of practice patterns of 20 early- and mid-career Mohs surgeons. Dermatol Surg. 2010;36(12):1915–20.PubMedCrossRefGoogle Scholar
  21. 21.
    Solan JM, Brady LW. Skin cancer. In: Halperin EC, Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. p. 690–700.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Lake Erie College of Osteopathic MedicineErieUSA
  2. 2.Division of Dermatology, Florida State University College of MedicineDermatology Associates of TallahasseeTallahasseeUSA

Personalised recommendations